A Multicenter Non-Interventional Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
Phase of Trial: Phase IV
Latest Information Update: 11 Jan 2017
At a glance
- Drugs Brincidofovir (Primary)
- Indications Adenovirus infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chimerix
- 05 Jan 2017 Status changed from completed to discontinued.
- 10 Nov 2016 Status changed from recruiting to completed.
- 10 Nov 2015 New trial record